Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection

Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection
复制标题

DOI:
10.1002/cpt.1432
复制
发表时间:
2019-08-01
影响因子:
6.7
通讯作者:
Muller, Daniel J.
Muller, Daniel J.
中科院分区:
医学2区
文献类型:
--
作者:
Bousman, Chad A.;Zierhut, Heather;Muller, Daniel J.

文献摘要

被引文献

相似文献

许多商业实验室在美国和国外提供临床药物遗传学测试。随着许多药物遗传学测试的选择,医疗保健提供者(例如,药剂师、医生、遗传咨询师)通常负责决定哪种测试最适合他们的患者和临床实践的需要。不幸的是,没有关于如何选择具有适当分析和临床有效性的测试的指南。在这里,我们提供的信息和资源,以协助供应商在识别和选择适当的药物遗传学测试。
Numerous commercial laboratories offer clinical pharmacogenetic testing in the United States and abroad. With many pharmacogenetic testing choices, healthcare providers (e.g., pharmacists, physicians, genetic counselors) are often tasked with deciding which test best suits the needs of their patients and clinical practice. Unfortunately, no guidelines exist on how to select a test with appropriate analytical and clinical validity. Here, we provide information and resources to assist providers in the identification and selection of appropriate pharmacogenetic tests.